Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 283 entries
View as:

Efficiency and Safety of Different Treatment Strategies in Adults With Pituitary Adenomas With Hypothalamic Involvement

Phase: N/A Priority: Normal
NCT ID: NCT04863456 Org: User:
Start: 05/01/21 End: 12/31/24 Due: 12/31/25

A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT06685887 Org: User:
Start: 02/15/25 End: 12/31/27 Due: 12/31/28

Research on the Mechanism Affecting Progression of Bronchiectasis

Phase: N/A Priority: Normal
NCT ID: NCT05731427 Org: User:
Start: 02/01/21 End: 02/01/26 Due: 02/01/27

Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT

Phase: N/A Priority: Normal
NCT ID: NCT06241274 Org: User:
Start: 08/15/24 End: 12/31/25 Due: 12/31/26

Effect of Airway Pressure Release Ventilation on Right Ventricular Function Assessed by Transthoracic Echocardiography

Phase: N/A Priority: Normal
NCT ID: NCT05414110 Org: User:
Start: 04/03/22 End: 02/15/24 Due: 02/15/25

A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT06367075 Org: User:
Start: 05/01/24 End: 03/31/29 Due: 03/31/30

Radiomics Combined With Frozen Section Prediction Model for Spread Through Air Space in Lung Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05400304 Org: User:
Start: 07/01/22 End: 05/12/23 Due: 05/12/24

Multi-dimensional Signatures for Precisely Predicting the Response and Prognosis of Lung Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04980352 Org: User:
Start: 01/01/21 End: 12/30/24 Due: 12/30/25

Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05097248 Org: User:
Start: 10/31/21 End: 10/31/24 Due: 10/31/25

Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06484153 Org: User:
Start: 07/22/24 End: 12/30/26 Due: 12/30/27

Safety and Efficacy of PRG-1801 in Recurrent/Refractory Immune Thrombocytopenia (ITP)

Phase: N/A Priority: Normal
NCT ID: NCT06519565 Org: User:
Start: 08/20/24 End: 08/15/27 Due: 08/15/28

Different Doses of Colchicine on hsCRP

Phase: N/A Priority: Normal
NCT ID: NCT06078904 Org: User:
Start: 10/10/23 End: 04/15/24 Due: 04/15/25

Application of 18F-CP6A PET Imaging in Synucleinopathies

Phase: N/A Priority: Normal
NCT ID: NCT06827821 Org: User:
Start: 02/17/25 End: 12/31/26 Due: 12/31/27

Effect of APRV and LTV on Lung Ventilation and Perfusion in Patients With Moderate-to-severe ARDS

Phase: N/A Priority: Normal
NCT ID: NCT05767125 Org: User:
Start: 01/01/23 End: 12/31/24 Due: 12/31/25

Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05830812 Org: User:
Start: 01/01/23 End: 12/31/26 Due: 12/31/27

Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction

Phase: N/A Priority: Normal
NCT ID: NCT06250894 Org: User:
Start: 03/30/21 End: 03/30/25 Due: 03/30/26

Anti-FLT3 CAR-T Cell (TAA05 Cell Injection) in the Treatment of Relapsed / Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT05445011 Org: User:
Start: 06/14/22 End: 06/14/27 Due: 06/14/28

An Experimental Study on the Effect of Tenofovir Amibufenamide on Blood Lipid During Anti-HBV Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05398393 Org: User:
Start: 01/01/22 End: 06/30/23 Due: 06/30/24

PK/PD Properties and Safety of Remazolam Besylate for Injection in ICU Patients With Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT06153498 Org: User:
Start: 11/04/23 End: 12/31/24 Due: 12/31/25

The Therapeutic Effect of Immunotherapy in Patients With Advanced Lung Squamous Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06647836 Org: User:
Start: 01/01/21 End: 12/31/27 Due: 12/31/28

RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT06732492 Org: User:
Start: 10/31/24 End: 12/31/27 Due: 12/31/28

Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05426135 Org: User:
Start: 06/01/22 End: 10/31/26 Due: 10/31/27

Study of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05527821 Org: User:
Start: 09/30/22 End: 09/30/25 Due: 09/30/26

The Clinical Study on the Treatment of SSc With UTAA91 Injection.

Phase: N/A Priority: Normal
NCT ID: NCT07000682 Org: User:
Start: 06/30/25 End: 01/31/40 Due: 01/31/41

The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection

Phase: N/A Priority: Normal
NCT ID: NCT07001956 Org: User:
Start: 06/30/25 End: 06/30/40 Due: 06/30/41